This Week in Psychedelics - 4.10.20

ThisWeekinPsychedelics.png

Cannabis

  • Delaware Approves Medical Cannabis Delivery Option (NORML)

  • New York Legal Marijuana Push ‘Effectively Over’ For 2020, Governor Says (Forbes)

  • North Dakota Activists Say Marijuana Legalization Initiative Unlikely In 2020 Due To Coronavirus (Marijuana Moment)

  • Cannabis Workers Claim Unsafe Conditions After Testing Positive for Coronavirus (MERRY JANE)

  • Participate in a Confidential Survey Assessing Cannabis Use Patterns During the COVID-19 Pandemic (NORML)

  • More People Are Seeking Medical Marijuana Cards Amid Coronavirus Outbreak (WBUR)

  • Coronavirus gave cannabis companies a big bump in sales and it wasn’t just for the wake-and-bake set (Fortune)

  • DEA loosens rules on prescription CBD drug Epidiolex (Leafly)

  • Adult-Use Pot Shops Are Supplying Medical Dispensaries with Weed During Pandemic (MERRY JANE)

  • Colorado Girl Who Inspired 'Charlotte's Web' Medical Marijuana Oil Dies at 13 (TIME)

  • Legal Marijuana States Had Fewer Vaping-Related Lung Injuries, Study Finds (Marijuana Moment)

  • Trump Hires Anti-Marijuana White House Press Secretary (Forbes)

  • Legalisation of cannabis in America has led to surge of drug imports to UK, reveals National Crime Agency (The Telegraph)

  • DEA continues to make empty promises on clinical cannabis research (The Hill)

  • Two Marijuana Magazines Owned By High Times Suspend Publication Due To Coronavirus (Marijuana Moment)

  • Septic shock: Did tainted CBD contribute to this woman’s death? (Leafly)

  • FBI Policy On CBD Use By Agents Is ‘Under Review’ (Marijuana Moment)

  • Ireland's Drug Users Switching From Cocaine to Cannabis Amid COVID-19 Crisis (MERRY JANE)

  • Arizona Legal Marijuana Campaign Asks Supreme Court To Allow Electronic Signatures Amid Coronavirus (Marijuana Moment)

  • Florida researchers studying COVID-19 impact on marijuana users (KNOE)

  • Businesses That ‘Indirectly’ Work With Marijuana Industry Ineligible For Federal Coronavirus Loans (Marijuana Moment)

  • Rats develop cannabis-seeking behavior (Medical News Today)

  • Cannabis Withdrawal Syndrome Prevalent Among Regular Users (MD Magazine)

Magic Mushrooms

  • A single high dose of psilocybin alters brain function up to one month later (PsyPost)

  • Psilocybin Is Better at Treating Depression Than Ketamine, New Study Finds (MERRY JANE)

  • New Biosynthesis of Psilocybin and Related Tryptamines (Psychedelic Science Review)

  • Challenges to a Company’s Psilocybin Patent Highlight Contrasting Business Strategies for Developers of Psychedelic Therapies (Lucid News)

  • Psilocybin Superior to Ketamine for Prolonged Antidepressant-Like Effects (Rodent Model) (Psychedelic Science Review)

  • Beyond Psilocybe Cubensis: 10 Magic Mushroom Strains You Should Know About (DoubleBlind)

  • Treating Trauma with Psilocybin (Oregon Daily Herald)

  • How Microdosing Magic Mushrooms Can Change Your Life (VENTS Magazine)

DMT

  • This Startup is Developing a DMT-Based Addiction Treatment (DoubleBlind)

Ayahuasca

  • The Ultimate Guide to Iowaska (Ayahuasca) (Kahpi)

  • Ayahuasca and the Amazon (LIMINAL)

Peyote

  • Southern Comfort: Why People in Rural Alabama Are Turning to Peyote Instead of Therapy (MERRY JANE)

Iboga

  • Interview about Bwiti initiation and iboga with Nima Grégory Puente (LIMINAL)

Ketamine

  • A Disgraced Ex-Doctor Says He's Behind the Use of Ketamine to 'Cure' a Child with Autism (VICE)

  • IV Esketamine, Ketamine Equally Effective for Resistant Depression (Medscape)

Datura

  • Twelve taken ill after consuming ‘coronavirus shaped’ datura seeds (The Hindu)

Miscellaneous

  • We Could Be Taking Psychedelics to Help Treat Mental Illness in Just Five Years (Newsweek)

  • Why coronavirus is making people hoard illegal drugs (Citizen TV)

  • Amidst Pandemic, Psychedelic Investor Christan Angermayer Can't Imagine Life Beyond Capitalism (Psymposia)

  • Psychedelic drugs like LSD and magic mushrooms could help treat mental health issues, study claims (Metro)

  • How Israel has become an unexpected leader in medicinal psychedelics (ISRAEL21c)

  • How psychedelic clinical trials are being affected by coronavirus (Psymposia)

  • National Psychedelics Advocacy Group Takes Next Step In Movement (Marijuana Moment)

  • Scientists Discover Intricacies of Serotonin Receptor Crucial for Better Therapeutics (UNC Health and UNC School of Medicine Newsroom)

  • If You Can’t Go Out, Go In: How Psychedelics Make Quarantine a Time of Self Renewal (DoubleBlind)

  • Why Some People Have Weird Drug Reactions (VICE)

  • Life During Lockdown: Psychedelics, Prison and COVID-19 (Scales)

  • Field Trip Psychedelics Inc. Announces Creation of Field Trip Discovery, the Company's Drug Development Division (PR Newswire)

  • Psychedelics in Addiction Recovery: Taking a Deep Look at “Sober” Communities that Use Psychedelics (Psychedelics Today)

  • Integration: The Upside of Coming Down – Debriefing, Disrupting & Dark Journeys (Chacruna)

  • Should FDA Fast-Track Psychedelic Treatment Under Coronavirus Pandemic? (The Fresh Toast)

  • Magic mushrooms, ayahuasca and LSD can all act as catalysts of connection to the natural world (Ecohustler)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.